<aside> 💡 Classified under "general health and wellness”, our devices and cloud infrastructure solution can be purchases through individual HSA (Health Savings Account) and FSA (Flexible Spending Account) or institutes can purchase through private grants or operational budgets.

To offer consumer wellness headbands as a recreational or relaxation amenity, facilities must fund them directly through their own operational capital, private technology grants, or donation foundations.

</aside>

Designing a Phase I clinical trial for remote neurofeedback in Silicon Valley’s eldercare facilities requires navigating the boundary between FDA-regulated medical device research and exempt wellness research. To avoid regulatory "flags" with the FDA or an Institutional Review Board (IRB), your strategy must center on non-invasive monitoring, a non-significant risk (NSR) profile, and explicit safety endpoints.

The following structure outlines how to design this protocol legally and efficiently within the California biotech ecosystem.

1. Regulatory Strategy & FDA Framework

To conduct this study without filing an Investigational Device Exemption (IDE) with the FDA, you must qualify as a Non-Significant Risk (NSR) study under 21 CFR 812.3(m).

• Utilize Cleared Hardware: Only use EEG headsets that already hold FDA 510(k) clearance or are registered as Class I exempt wellness devices (e.g., Muse or BrainMaster).
• Avoid Diagnostic Claims: Do not frame the study as a "treatment" or "cure" for Alzheimer's disease or clinical dementia.
• Focus on Wellness Endpoints: Define your target outcomes around general cognitive wellness, such as improving sleep quality, reducing situational anxiety, or enhancing focus during daily tasks.
• The IRB Rule: You cannot bypass the IRB entirely, as testing on human subjects requires oversight. However, an NSR designation allows the IRB to act as the sole regulatory authority, bypassing the need for direct FDA IDE submission.

2. Clinical Protocol Design

A Phase I trial focuses primarily on safety, tolerability, and feasibility. [4]

• Study Cohort: Recruit a small sample size (N = 10 to 20) of stable residents within a local memory care or assistive living facility.
• Primary Endpoints: Track skin tolerability under the headset sensors, fatigue levels after training sessions, and adherence to the daily schedule.
• Secondary Endpoints: Use simple, established cognitive metrics like the Mini-Mental State Examination (MMSE) or the Montreal Cognitive Assessment (MoCA) to gather baseline and post-study scientific evidence.
• Session Duration: Limit sessions to 15–20 minutes, 2 to 3 times per week, over a short 4-week window to minimize cognitive fatigue in elderly participants.

General Wellness Metrics

3. Local Execution & Ecosystem Integration